93 related articles for article (PubMed ID: 9590434)
1. Prion protein fragment interacts with PrP-deficient cells.
Brown DR; Schmidt B; Kretzschmar HA
J Neurosci Res; 1998 May; 52(3):260-7. PubMed ID: 9590434
[TBL] [Abstract][Full Text] [Related]
2. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
[TBL] [Abstract][Full Text] [Related]
3. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126.
Salmona M; Malesani P; De Gioia L; Gorla S; Bruschi M; Molinari A; Della Vedova F; Pedrotti B; Marrari MA; Awan T; Bugiani O; Forloni G; Tagliavini F
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):207-14. PubMed ID: 10432318
[TBL] [Abstract][Full Text] [Related]
4. Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126.
Stewart LR; White AR; Jobling MF; Needham BE; Maher F; Thyer J; Beyreuther K; Masters CL; Collins SJ; Cappai R
J Neurosci Res; 2001 Sep; 65(6):565-72. PubMed ID: 11550224
[TBL] [Abstract][Full Text] [Related]
5. Mouse cortical cells lacking cellular PrP survive in culture with a neurotoxic PrP fragment.
Brown DR; Herms J; Kretzschmar HA
Neuroreport; 1994 Oct; 5(16):2057-60. PubMed ID: 7865744
[TBL] [Abstract][Full Text] [Related]
6. Altered toxicity of the prion protein peptide PrP106-126 carrying the Ala(117)-->Val mutation.
Brown DR
Biochem J; 2000 Mar; 346 Pt 3(Pt 3):785-91. PubMed ID: 10698707
[TBL] [Abstract][Full Text] [Related]
7. Cellular uptake of the prion protein fragment PrP106-126 in vitro.
McHattie SJ; Brown DR; Bird MM
J Neurocytol; 1999 Feb; 28(2):149-59. PubMed ID: 10590514
[TBL] [Abstract][Full Text] [Related]
8. Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation.
Corsaro A; Thellung S; Villa V; Principe DR; Paludi D; Arena S; Millo E; Schettini D; Damonte G; Aceto A; Schettini G; Florio T
Ann N Y Acad Sci; 2003 Dec; 1010():610-22. PubMed ID: 15033801
[TBL] [Abstract][Full Text] [Related]
9. Prion protein-overexpressing cells show altered response to a neurotoxic prion protein peptide.
Brown DR
J Neurosci Res; 1998 Nov; 54(3):331-40. PubMed ID: 9819138
[TBL] [Abstract][Full Text] [Related]
10. Prion protein-deficient neurons reveal lower glutathione reductase activity and increased susceptibility to hydrogen peroxide toxicity.
White AR; Collins SJ; Maher F; Jobling MF; Stewart LR; Thyer JM; Beyreuther K; Masters CL; Cappai R
Am J Pathol; 1999 Nov; 155(5):1723-30. PubMed ID: 10550328
[TBL] [Abstract][Full Text] [Related]
11. PrPSc-like prion protein peptide inhibits the function of cellular prion protein.
Brown DR
Biochem J; 2000 Dec; 352 Pt 2(Pt 2):511-8. PubMed ID: 11085945
[TBL] [Abstract][Full Text] [Related]
12. PrP fragment 106-126 is toxic to cerebral endothelial cells expressing PrP(C).
Deli MA; Sakaguchi S; Nakaoke R; Abrahám CS; Takahata H; Kopacek J; Shigematsu K; Katamine S; Niwa M
Neuroreport; 2000 Nov; 11(17):3931-6. PubMed ID: 11117517
[TBL] [Abstract][Full Text] [Related]
13. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D
Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
[TBL] [Abstract][Full Text] [Related]
14. PrP and beta-amyloid fragments activate different neurotoxic mechanisms in cultured mouse cells.
Brown DR; Herms JW; Schmidt B; Kretzschmar HA
Eur J Neurosci; 1997 Jun; 9(6):1162-9. PubMed ID: 9215699
[TBL] [Abstract][Full Text] [Related]
15. Apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment 106-126.
Thellung S; Florio T; Villa V; Corsaro A; Arena S; Amico C; Robello M; Salmona M; Forloni G; Bugiani O; Tagliavini F; Schettini G
Neurobiol Dis; 2000 Aug; 7(4):299-309. PubMed ID: 10964602
[TBL] [Abstract][Full Text] [Related]
16. Effect of flupirtine on Bcl-2 and glutathione level in neuronal cells treated in vitro with the prion protein fragment (PrP106-126).
Perovic S; Schröder HC; Pergande G; Ushijima H; Müller WE
Exp Neurol; 1997 Oct; 147(2):518-24. PubMed ID: 9344576
[TBL] [Abstract][Full Text] [Related]
17. Internalization of PrP106-126 by the formyl-peptide-receptor-like-1 in glial cells.
Brandenburg LO; Koch T; Sievers J; Lucius R
J Neurochem; 2007 May; 101(3):718-28. PubMed ID: 17448144
[TBL] [Abstract][Full Text] [Related]
18. The neurotoxicity of prion protein (PrP) peptide 106-126 is independent of the expression level of PrP and is not mediated by abnormal PrP species.
Fioriti L; Quaglio E; Massignan T; Colombo L; Stewart RS; Salmona M; Harris DA; Forloni G; Chiesa R
Mol Cell Neurosci; 2005 Jan; 28(1):165-76. PubMed ID: 15607951
[TBL] [Abstract][Full Text] [Related]
19. Aspirin inhibits cytotoxicity of prion peptide PrP106-126 to neuronal cells associated with microglia activation in vitro.
Yang L; Zhou X; Yang J; Yin X; Han L; Zhao D
J Neuroimmunol; 2008 Aug; 199(1-2):10-7. PubMed ID: 18547651
[TBL] [Abstract][Full Text] [Related]
20. Zinc, copper, and carnosine attenuate neurotoxicity of prion fragment PrP106-126.
Kawahara M; Koyama H; Nagata T; Sadakane Y
Metallomics; 2011 Jul; 3(7):726-34. PubMed ID: 21442127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
